Fermenta Biotech Confirms No 'Large Corporate' Status

Fermenta Biotech has confirmed it does not meet SEBI's criteria for a 'Large Corporate'. This announcement means the company will avoid stricter listing and disclosure obligations. The confirmation comes after the company reported outstanding borrowings totaling ₹17.39 crore as of March 31, 2026.

The company officially made this disclosure on April 28, 2026, adhering to SEBI and BSE circulars. CARE Ratings Limited has confirmed Fermenta Biotech's credit rating remains CARE BBB; Stable, which signifies a moderate risk profile.

SEBI defines 'Large Corporates' typically based on long-term borrowings of at least ₹1,000 crore and a credit rating of 'AA' or higher. Fermenta Biotech's debt level of ₹17.39 crore falls significantly below this threshold. Consequently, it is exempt from the 'Large Corporate' classification and its associated enhanced listing obligations and disclosure requirements (LODR).

For shareholders and the company, this clarification simplifies the regulatory landscape. Fermenta Biotech will continue to operate under standard corporate compliance rules, which may lead to more streamlined reporting processes.

Several other listed companies, including Magellanic Cloud Limited, A-1 Ltd, and NIS Management Limited, have recently made similar disclosures confirming they do not meet SEBI's 'Large Corporate' debt and rating criteria. Investors will be monitoring Fermenta Biotech's future debt profile and credit ratings for any changes that could alter its classification.